These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19836496)

  • 21. [Treatment of adrenal cortex carcinoma].
    Roelofs EJ; de Mulder PH; Hermus AR
    Ned Tijdschr Geneeskd; 1993 Dec; 137(50):2576-9. PubMed ID: 8277982
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial.
    Hubertus J; Boxberger N; Redlich A; von Schweinitz D; Vorwerk P
    Klin Padiatr; 2012 Apr; 224(3):143-7. PubMed ID: 22504769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The next generation of therapies for adrenocortical cancers.
    Kirschner LS
    Trends Endocrinol Metab; 2012 Jul; 23(7):343-50. PubMed ID: 22626690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adrenocortical carcinoma].
    Gur C; Salmon A; Silvetski N; Gross DJ
    Harefuah; 2008 Jun; 147(6):520-5, 574. PubMed ID: 18693629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chloditane therapy of adrenocortical cancer].
    Kvacheniuk AM
    Lik Sprava; 2004 Dec; (8):64-7. PubMed ID: 15771076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy in a patient with adrenal carcinoma treated with mitotane: a case report and review of literature.
    Tripto-Shkolnik L; Blumenfeld Z; Bronshtein M; Salmon A; Jaffe A
    J Clin Endocrinol Metab; 2013 Feb; 98(2):443-7. PubMed ID: 23275528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.
    Demeure MJ; Stephan E; Sinari S; Mount D; Gately S; Gonzales P; Hostetter G; Komorowski R; Kiefer J; Grant CS; Han H; Von Hoff DD; Bussey KJ
    Ann Surg; 2012 Jan; 255(1):140-6. PubMed ID: 22156929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical management of adrenocortical carcinoma.
    Fassnacht M; Allolio B
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical resection of a virilizing adrenal mass with extensive tumor thrombus.
    Gahan J; Shirodkar SP; Gorin MA; Salerno TA; Ciancio G
    Can J Urol; 2011 Jun; 18(3):5735-8. PubMed ID: 21703051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term recurrence-free survival of adrenocortical cancer extending into the inferior vena cava and right atrium: Case report and literature review.
    Alghulayqah A; Alghasab N; Amin T; Alkahtani N; Farhat R; Alzahrani AS
    Medicine (Baltimore); 2017 May; 96(18):e6751. PubMed ID: 28471969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.
    Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M
    Expert Rev Anticancer Ther; 2018 Nov; 18(11):1125-1133. PubMed ID: 30117750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Favorable outcome of a recurring malignant adrenocortical tumor under O,P'-DDD therapy].
    Levy JM; Lutz P; Wagner C; Sauer P; Seiller F; Fischbach M; Segura N; Sauvage P
    Ann Pediatr (Paris); 1985 Jun; 32(6):541-4. PubMed ID: 4026152
    [No Abstract]   [Full Text] [Related]  

  • 35. [German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment].
    Reibetanz J; Kroiss M; Deutschbein T; Fenske W; Gasser M; Jurowich C; Germer CT; Allolio B; Fassnacht M
    Chirurg; 2012 Jun; 83(6):528-35. PubMed ID: 22585346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly.
    Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M
    Endocr Relat Cancer; 2008 Dec; 15(4):1043-53. PubMed ID: 18824557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant mitotane for adrenocortical cancer--working through uncertainty.
    Terzolo M; Fassnacht M; Ciccone G; Allolio B; Berruti A
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1879-80. PubMed ID: 19494162
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant mitotane for adrenocortical cancer--a recurring controversy.
    Huang H; Fojo T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3730-2. PubMed ID: 18842984
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of adrenocortical carcinomas in children].
    Leblond P; Delebarre M; Aubert S
    Bull Cancer; 2011 May; 98(5):595-605. PubMed ID: 21596653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in adrenocortical carcinoma in adults.
    Bourdeau I; MacKenzie-Feder J; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.